{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-095491","form_type":"8-K","ticker":"MGTX","cik":"0001735438","company_name":"MeiraGTx Holdings plc","filed_at":"2026-08-13T12:05:59+00:00","discovered_at":"2026-08-13T12:10:01.193680+00:00","generated_at":"2026-08-13T12:10:11.423008+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"MeiraGTx Q2 net income $160.7M; bota-vec acquired, $400M Oberland deal, BTD for AAV2-hAQP1","bullets":["Q2 net income $160.7M ($1.76 basic EPS) vs net loss $38.8M in Q2 2025; revenue from services and licenses surged.","Completed $25M acquisition of bota-vec (XLRP) from J&J; $100M equity financing; up to $400M Oberland investment with $375M non-dilutive.","FDA granted Breakthrough Therapy Designation for AAV2-hAQP1; Phase 2 AQUAx2 enrollment completed; 3-year data positive.","Lilly collaboration: $75M upfront, up to $400M milestones for medu-vec and gene therapy tech; also $95M due from Hologen.","Cash $145.4M at June 30, 2026; expects runway into H2 2028."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-095491","json":"https://secwatch.observer/filing/0001104659-26-095491.json","markdown":"https://secwatch.observer/filing/0001104659-26-095491.md","text":"https://secwatch.observer/filing/0001104659-26-095491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735438/000110465926095491/0001104659-26-095491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735438/000110465926095491/mgtx-20260813x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T12:10:11.423008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}